BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19303222)

  • 1. [Abdominal migration of a levonorgestrel-releasing intrauterine device. Case report and review of the literature].
    Pont M; Lantheaume S
    J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):179-81. PubMed ID: 19303222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine device and uterine perforations.
    Prescrire Int; 2007 Dec; 16(92):248-9. PubMed ID: 18092420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levonorgestrel-releasing intrauterine device (Mirena) and breast cancer: what do we learn from literature for clinical practice?].
    Boutet G
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1015-23. PubMed ID: 17092752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intra-uterine systems (LNG-IUS) and breast cancer.
    Neven P; Amant F; Poppe W; Van den Broecke R
    Fertil Steril; 2009 Apr; 91(4):e5; author reply e6. PubMed ID: 19249759
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravesical migration of levonorgestrel-releasing intrauterine system (LNG-IUS) with calculus formation.
    Khan ZA; Khan SA; Williams A; Mobb GE
    Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):243-5. PubMed ID: 17056458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in a patient with a displaced levonorgestrel-releasing intrauterine system: a case report.
    Budiman H; Kümper C; Mylonas I; Thaler CJ; Friese K; Weissenbacher ER
    Arch Gynecol Obstet; 2007 Sep; 276(3):263-4. PubMed ID: 17356827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe seborrhoeic dermatitis: side-effect of the Mirena intra-uterine system.
    Karri K; Mowbray D; Adams S; Rendal JR
    Eur J Contracept Reprod Health Care; 2006 Mar; 11(1):53-4. PubMed ID: 16546818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migration of levonorgestrel IUS in a patient with complex medical problems: what should be done?
    Soleymani Majd H; El Hamamy E; Chandrasekar R; Ismail L
    Arch Gynecol Obstet; 2009 Mar; 279(3):385-6. PubMed ID: 18568357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system.
    Hidalgo MM; Hidalgo-Regina C; Bahamondes MV; Monteiro I; Petta CA; Bahamondes L
    Contraception; 2009 Jul; 80(1):84-9. PubMed ID: 19501221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algorithm for nonvisible strings of levonorgestrel intrauterine system.
    Vilos GA; Di Cecco R; Marks J
    J Minim Invasive Gynecol; 2010; 17(6):805-6. PubMed ID: 20955995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation.
    Haimov-Kochman R; Doviner V; Amsalem H; Prus D; Adoni A; Lavy Y
    Hum Reprod; 2003 May; 18(5):990-3. PubMed ID: 12721174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment of dysfunctional uterine bleeding.
    Bongers MY; Mol BW; Brölmann HA
    Maturitas; 2004 Mar; 47(3):159-74. PubMed ID: 15036486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levonorgestrel-releasing intrauterine system: why do some women dislike it?
    Daud S; Ewies AA
    Gynecol Endocrinol; 2008 Dec; 24(12):686-90. PubMed ID: 19172537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaginal flora changes on Pap smears after insertion of levonorgestrel-releasing intrauterine device.
    Donders GG; Berger J; Heuninckx H; Bellen G; Cornelis A
    Contraception; 2011 Apr; 83(4):352-6. PubMed ID: 21397094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The levonorgestrel intrauterine system in nulliparous women.
    Prager S; Darney PD
    Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
    Li CF; Lee SS; Pun TC
    Contraception; 2004 Mar; 69(3):247-50. PubMed ID: 14969674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subject and clinician experience with the levonorgestrel-releasing intrauterine system.
    Jensen JT; Nelson AL; Costales AC
    Contraception; 2008 Jan; 77(1):22-9. PubMed ID: 18082662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the levonorgestrel-releasing intrauterine system in women with hemostatic disorders.
    Lukes AS; Reardon B; Arepally G
    Fertil Steril; 2008 Sep; 90(3):673-7. PubMed ID: 18001734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.